AABB is urging hospitals to remain highly vigilant in managing their blood inventories, especially type O negative red blood cells and AB plasma, as these products are in short supply this summer. AABB recommends hospitals reserve AB plasma for blood group AB patients with definitive transfusion needs. For situations where type O negative red blood cells and AB plasma are used as part of a massive transfusion protocol for patients of unknown blood type, every effort should be made to obtain a blood type for the patient as soon as possible. “Maintaining a safe and adequate blood supply is critical to the nation’s public health and a priority for the medical community,” said Miriam A. Markowitz, CEO of AABB. Hospitals are urged to follow available clinical practice guidelines for the appropriate use of individual blood products. AHA and AABB collaborated on a toolkit to assist hospitals as they implement a patient blood management approach as a component of their care planning decisions. 

Related News Articles

Headline
The House May 22 passed the fiscal year 2025 budget reconciliation bill, the One Big Beautiful Bill Act by a 215-214 vote. The legislation includes significant…
Headline
The White House May 22 released its Make America Healthy Again report that focuses on childhood chronic disease. The report highlights findings from the MAHA…
Headline
The Departments of Labor, Health and Human Services, and the Treasury May 22 released several new guidance documents and requests for information on price…
Headline
The Centers for Medicare & Medicaid Services May 21 announced it will immediately begin annual audits of all Medicare Advantage plans and work to clear a…
Headline
Food and Drug Administration Commissioner Marty Makary testified May 22 before the Senate Appropriations Subcommittee on Agriculture, Rural Development, Food…
Headline
The Administration for Strategic Preparedness and Response May 21 released a bulletin on workplace violence in health care that includes recommendations for…